How should heart failure be classified and staged for clinical management?
Heart failure classification uses both the New York Heart Association (NYHA) functional classification (I-IV based on symptom severity) and the ACC/AHA stages (A-D based on disease progression). Stage A identifies at-risk patients, Stage B indicates structural disease without symptoms, Stage C encompasses symptomatic heart failure, and Stage D represents refractory end-stage disease requiring advanced therapies.
Educational summary; not medical advice. Consult local guidelines and clinician judgment.
NYHA Functional Classification
NYHA Class I indicates no limitation of physical activity. Class II involves slight limitation with ordinary activity causing symptoms. Class III shows marked limitation where less than ordinary activity causes symptoms. Class IV patients are unable to carry on any physical activity without discomfort and may have symptoms at rest.
ACC/AHA Staging System
Stage A patients are at high risk but have no structural disease or symptoms. Stage B indicates structural heart disease without signs or symptoms. Stage C encompasses structural disease with prior or current symptoms. Stage D represents refractory heart failure requiring specialized interventions such as mechanical support or transplantation.
Ejection Fraction Categories
Heart failure is further classified by left ventricular ejection fraction: HFrEF (reduced, ≤40%), HFmrEF (mildly reduced, 41-49%), and HFpEF (preserved, ≥50%). Each category has distinct pathophysiology and treatment approaches, though foundational therapies like diuretics apply across categories.
Points of Disagreement
Minor variation exists regarding the clinical utility of HFmrEF as a distinct category versus a transitional state.
Multi-Guideline Agreement: High (94%)
Consensus Models: Gemini 3, Gemini 3 Pro, Sonnet 4.5, GPT 5.2
External Auditors: Grok 4, Opus 4.5
Last reconciled: December 31, 2025 | Version: 1.0